Comparison of the clinical efficacy of AcrySof<sup>®</sup> IQ and TECNIS<sup>®</sup> toric intraocular lenses: A real‑world study

作者：Juanjuan Yang, Yazhou Qin, Qin Li, Jingming Li · 发表于：Experimental and Therapeutic Medicine · 年份：2020 · DOI：10.3892/etm.2020.9153 · 被引用次数：11 · 研究领域：Ophthalmology and Visual Impairment Studies、Corneal surgery and disorders、Intraocular Surgery and Lenses

Corneal astigmatism significantly compromises uncorrected visual acuity (UCVA) after phacoemulsification with implantation of traditional spherical or non‑spherical monofocal intraocular lens (IOL). Toric IOL provides an effective way to gain favorable postoperative UCVA for the patients with cataracts with corneal astigmatism. There are numerous types of toric IOLs; however AcrySof ® IQ toric IOL (Alcon Laboratories, Inc.) and TECNIS ® toric IOL (Johnson & Johnson Vision; Johnson & Johnson) are most frequently used in our clinical practice. The purpose of the current study was to compare the clinical efficacy of AcrySof IQ with TECNIS toric IOL implantation, and to provide a clinical basis on selecting an appropriate toric IOL before cataract surgery for patients with corneal astigmatism. A total of 30 patients with cataract (44 eyes) with corneal astigmatism [0.82‑7.27 diopters (D)], who have undergone phacoemulsification with toric IOL implantation between October 2012 and December 2017, were included in the current retrospective cohort study. Patients were divided into two groups: One group (26 eyes) received the AcrySof IQ toric IOL (AcrySof group) and the other group (18 eyes) received the TECNIS toric IOL (Tecnis group). The indexes of curative effect, such as uncorrected and corrected distance visual acuity (UDVA and CDVA, respectively), refractive outcomes, contrast sensitivity (CS), IOL rotatio...